![](https://i-invdn-com.investing.com/news/LYNXMPED0C0KP_L.jpg)
Earnings call: Xenon Pharmaceuticals Q2 2024 results and clinical updates
Xenon (NASDAQ:XENE) Pharmaceuticals Inc. (ticker: XENE), a clinical-stage biopharmaceutical company, has provided a comprehensive update on its financial health and the progress of its clinical programs during its Q2 2024 earnings call. The company has …